US Stocks
/
Aligos Therapeutics, Inc. Share Price
Aligos Therapeutics, Inc. Share Price

Aligos Therapeutics, Inc. Share Price

NASDAQ: ALGS | Micro Cap
$5.18
+$5.18 (--%) Last updated on 29 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aligos Therapeutics, Inc. Stock Performance

Open
$4.78
Prev. Close
N/A
Circuit Range
N/A
Day Range
$4.78 - $5.05
Year Range
$4.01 - $13.58
Volume
852
Average Traded
$4.96

Aligos Therapeutics, Inc. Share Price Chart

$4.78$5.05
L
Show Current Price
H

Aligos Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$51.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-12.16
Revenue (TTM)
$2.19B
Return On Equity (TTM)
-238.24%
Profit Margin
-1104.57%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
95.24%

Aligos Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.74$0.17$2.83$27.78
Net Profit-$31.54-$19.88-$23.04-$1.50
Net Profit Margin-4262.16%-11694.12%-814.13%-5.40%
Income ChangeN/A36.97%-15.90%93.49%

Aligos Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$13.91$15.53$3.95$2.19
Net Profit-$96.05-$87.68-$131.21-$24.19
Net Profit Margin-690.51%-564.58%-3321.77%-1104.57%
Income ChangeN/A8.71%-49.65%81.56%

About Aligos Therapeutics, Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Aligos Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$5.49
$5.05
-8.42%
Sep 2026
$5.65
$5.52
-21.92%
Aug 2026
$4.21
$7.07
+65.77%
Jul 2026
$5.65
$4.26
-25.63%
Jun 2026
$5.52
$5.74
+0.26%
May 2026
$6.16
$5.72
-5.61%
Apr 2026
$7.84
$6.06
-14.35%
Mar 2026
$6.73
$7.08
+2.09%
Feb 2026
$7.96
$6.93
-14.54%
Jan 2026
$9.21
$8.11
-13.92%
Dec 2025
$9.60
$9.42
-2.79%
Nov 2025
$7.76
$9.69
+16.54%

ALGS Share Price FAQs

What is Aligos Therapeutics, Inc. share price today?

chevron-up
Aligos Therapeutics, Inc. share price today is $5.18 as on October 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Aligos Therapeutics, Inc. stock?

chevron-up
The 52 week high of Aligos Therapeutics, Inc. stock is $13.58, while the 52 week low is $4.01 as of 29 Oct '26.

What is ALGS's market capitalisation today?

chevron-up
ALGS market capitalisation is $51.20M as of October 29, 2026, at 4:52 am IST.

What is ALGS's net income for the last quarter?

chevron-up
ALGS's net income for the last quarter is -1.50B USD.

What is the 5 year returns of ALGS?

chevron-up
The 5 year returns of ALGS is -98.70% as on 29 Oct '26.

What is the high & low stock price of ALGS today?

chevron-up
ALGS stock price hit a high of $5.05 and low of $4.78 as of 29 Oct '26.

Can I buy ALGS shares in India?

chevron-up
Yes. You can buy ALGS in India by opening an international trading account.